बायोफार्मा शक्ति योजना क्या है?
ऐतिहासिक पृष्ठभूमि
मुख्य प्रावधान
10 points- 1.
बायोफार्मास्युटिकल क्षेत्र में अनुसंधान और विकास परियोजनाओं के लिए वित्तीय सहायता प्रदान करता है।
- 2.
बायोफार्मा नवाचार के लिए एक अनुकूल वातावरण बनाने का लक्ष्य है।
- 3.
नई दवाओं और उपचारों के विकास का समर्थन करता है।
- 4.
उद्योग, शिक्षा जगत और सरकार के बीच सहयोग को बढ़ावा देता है।
- 5.
बायोफार्मास्युटिकल विनिर्माण सुविधाओं में निवेश को प्रोत्साहित करता है।
- 6.
बायोफार्मास्युटिकल उद्योग में एक कुशल कार्यबल विकसित करने पर ध्यान केंद्रित करता है।
- 7.
भारत को बायोफार्मास्युटिकल अनुसंधान और विनिर्माण के लिए एक वैश्विक केंद्र बनाने का लक्ष्य है।
- 8.
यह योजना भारत में बायोफार्मास्युटिकल उद्योग के विकास को बढ़ावा देने की उम्मीद है।
- 9.
यह योजना विभिन्न तंत्रों के माध्यम से लागू की जाएगी, जैसे कि अनुदान और सब्सिडी।
- 10.
यह सुनिश्चित करने के लिए योजना की निगरानी की जाएगी कि इसका प्रभावी ढंग से उपयोग किया जाए।
दृश्य सामग्री
Biopharma SHAKTI Scheme: Key Components and Objectives
Mind map illustrating the key components, objectives, and linkages of the Biopharma SHAKTI scheme.
Biopharma SHAKTI Scheme
- ●Objectives
- ●Key Components
- ●Beneficiaries
हालिया विकास
5 विकासThe scheme is currently in the planning stage.
The government is consulting with stakeholders to finalize the details of the scheme.
The scheme is expected to be launched in the near future.
The scheme is part of the government's broader strategy to promote innovation and research and development.
The scheme is subject to parliamentary approval.
सामान्य प्रश्न
61. What is the Biopharma SHAKTI scheme and why is it important for UPSC GS Paper 3?
The Biopharma SHAKTI scheme is a proposed government initiative designed to strengthen the biopharmaceutical sector in India by promoting research, development, and innovation. It is important for UPSC GS Paper 3 because it relates to Economic Development, Government Schemes, and Science and Technology, all of which are key areas of the syllabus. Questions on healthcare policy and government initiatives in the biopharmaceutical industry are likely to be asked.
परीक्षा युक्ति
Remember the key areas the scheme addresses: research, development, and innovation in the biopharmaceutical sector. Link it to broader economic and healthcare policy questions.
2. What are the key provisions that are expected to be included in the Biopharma SHAKTI scheme?
Based on the concept data, the key provisions of the Biopharma SHAKTI scheme are expected to include: * Financial support for research and development projects. * Creation of a conducive environment for biopharma innovation. * Support for the development of new drugs and therapies. * Promotion of collaboration between industry, academia, and government. * Encouragement of investment in biopharmaceutical manufacturing facilities.
- •Financial support for research and development projects
- •Creation of a conducive environment for biopharma innovation
- •Support for the development of new drugs and therapies
- •Promotion of collaboration between industry, academia, and government
- •Encouragement of investment in biopharmaceutical manufacturing facilities
परीक्षा युक्ति
Focus on the five key areas of the scheme's provisions. These can be used as points in Mains answers or as options in Prelims questions.
3. Which government body is expected to govern the Biopharma SHAKTI scheme?
As per the concept data, the Biopharma SHAKTI scheme is expected to be governed by the Department of Biotechnology (DBT), under the Ministry of Science and Technology.
परीक्षा युक्ति
Remember the parent ministry and department for accurate identification in prelims.
4. What are the potential challenges in the implementation of the Biopharma SHAKTI scheme?
Some potential challenges in implementing the Biopharma SHAKTI scheme include: * Securing sufficient and sustained funding for research and development. * Overcoming regulatory hurdles and streamlining approval processes. * Ensuring effective collaboration between industry, academia, and government. * Attracting and retaining skilled personnel in the biopharmaceutical sector. * Addressing the high costs associated with biopharmaceutical manufacturing.
- •Securing sufficient and sustained funding for research and development
- •Overcoming regulatory hurdles and streamlining approval processes
- •Ensuring effective collaboration between industry, academia, and government
- •Attracting and retaining skilled personnel in the biopharmaceutical sector
- •Addressing the high costs associated with biopharmaceutical manufacturing
5. What is the significance of the Biopharma SHAKTI scheme for the Indian economy?
The Biopharma SHAKTI scheme is significant for the Indian economy because it aims to boost the biopharmaceutical sector, which can lead to: * Increased investment in research and development. * Creation of new jobs in the biopharmaceutical industry. * Development of affordable and accessible drugs and therapies. * Reduced dependence on imports of biopharmaceutical products. * Enhanced global competitiveness of the Indian biopharmaceutical industry.
- •Increased investment in research and development
- •Creation of new jobs in the biopharmaceutical industry
- •Development of affordable and accessible drugs and therapies
- •Reduced dependence on imports of biopharmaceutical products
- •Enhanced global competitiveness of the Indian biopharmaceutical industry
6. How does the Biopharma SHAKTI scheme promote collaboration between different sectors?
The Biopharma SHAKTI scheme promotes collaboration between industry, academia, and government by: * Providing platforms for knowledge sharing and networking. * Encouraging joint research projects and partnerships. * Facilitating access to research facilities and infrastructure. * Creating a regulatory framework that supports collaboration. * Offering incentives for collaborative ventures.
- •Providing platforms for knowledge sharing and networking
- •Encouraging joint research projects and partnerships
- •Facilitating access to research facilities and infrastructure
- •Creating a regulatory framework that supports collaboration
- •Offering incentives for collaborative ventures